A Bioequivalence Study of Recombinant Human Follicle-Stimulating Hormone Injection Versus Recombinant Human Follitropin For Injection in Healthy Chinese Adult Women.

Drugs R D · 2025 · PMC12460200 · PMID 40650795

Europe PMC DOI

hedged sentence

0.1450

closest p · 2.9× alpha

0.1450

boldest claim

The sentences

did not reach statistical significancep = 0.145not close (p > 0.1)

A Wilcoxon sign test for the PK parameter T max showed that the difference between the T/R formulations did not reach statistical significance ( p = 0.145).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.